|
1
|
Siegel RL, Miller KD, Wagle NS and Jemal
A: Cancer statistics, 2023. CA Cancer J Clin. 73:17–48.
2023.PubMed/NCBI
|
|
2
|
Lheureux S, Braunstein M and Oza AM:
Epithelial ovarian cancer: Evolution of management in the era of
precision medicine. CA Cancer J Clin. 69:280–304. 2019.PubMed/NCBI
|
|
3
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang X, Wang W, Zhu W, Dong J, Cheng Y,
Yin Z and Shen F: Mechanisms and functions of long non-coding RNAs
at multiple regulatory levels. Int J Mol Sci. 20:55732019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Slack FJ and Chinnaiyan AM: The Role of
non-coding RNAs in oncology. Cell. 179:1033–1055. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li L, Zhang X, Liu N, Chen X and Peng C:
LINC00473: A novel oncogenic long noncoding RNA in human cancers. J
Cell Physiol. 236:4174–4183. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang WZ, Zhou H and Yan Y: XIAP underlies
apoptosis resistance of renal cell carcinoma cells. Mol Med Rep.
17:125–130. 2018.PubMed/NCBI
|
|
8
|
Yang L, Xie HJ, Li YY, Wang X, Liu XX and
Mai J: Molecular mechanisms of platinum-based chemotherapy
resistance in ovarian cancer (review). Oncol Rep. 47:822022.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zanconato F, Cordenonsi M and Piccolo S:
YAP/TAZ at the roots of cancer. Cancer Cell. 29:783–803. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen Y, Li Z, Chen X and Zhang S: Long
non-coding RNAs: From disease code to drug role. Acta Pharm Sin B.
11:340–354. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mo J, Li B, Zhou Y, Xu Y, Jiang H, Cheng
X, Wu X and Zhang Y: LINC00473 promotes hepatocellular carcinoma
progression via acting as a ceRNA for microRNA-195 and increasing
HMGA2 expression. Biomed Pharmacother. 120:1094032019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang JY, Lu AQ and Chen LJ: LncRNAs in
ovarian cancer. Clin Chim Acta. 490:17–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shankaraiah RC, Veronese A, Sabbioni S and
Negrini M: Non-coding RNAs in the reprogramming of glucose
metabolism in cancer. Cancer Lett. 419:167–174. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leeper NJ and Maegdefessel L: Non-coding
RNAs: Key regulators of smooth muscle cell fate in vascular
disease. Cardiovasc Res. 114:611–621. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Q, Wang G, Xu L, Yao Z and Song L:
Long non-coding RNA LINC00473 promotes glioma cells proliferation
and invasion by impairing miR-637/CDK6 axis. Artif Cells Nanomed
Biotechnol. 47:3896–3903. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu S, Fu W, Zhang L, Fu K, Hu J, Jia W
and Liu G: LINC00473 antagonizes the tumour suppressor miR-195 to
mediate the pathogenesis of Wilms tumour via IKKα. Cell Prolif.
51:e124162018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang H, Gao L, Chen Y, Zhang L, Bai Y,
Zhao C, Zhang L, Zuo L and Sun H: Identification of hub genes in
bladder transitional cell carcinoma through ceRNA network
construction integrated with gene network analysis. J Cell Mol Med.
28:e179792024. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Qian Y, Zhang C, Wang W, Qiao Y,
Song H, Li L, Guo J, Lu D and Deng X: LncRNA LINC00473 is involved
in the progression of invasive pituitary adenoma by upregulating
KMT5A via ceRNA-mediated miR-502-3p evasion. Cell Death Dis.
12:5802021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang C and Yang T: Long Non-coding RNA
LINC00473 promotes breast cancer progression via miR-424-5p/CCNE1
pathway. Protein Pept Lett. 30:72–84. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu SH, Bo YH, Ma HC, Zhang HN and Shao MJ:
lncRNA LINC00473 promotes proliferation, migration, invasion and
inhibition of apoptosis of non-small cell lung cancer cells by
acting as a sponge of miR-497-5p. Oncol Lett. 21:4292021.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu Y, Jiang Y, Wang Y, Zhao Z and Li T:
LINC00473 rescues human bone marrow mesenchymal stem cells from
apoptosis induced by dexamethasone through the PEBP1-mediated
Akt/Bad/Bcl-2 signaling pathway. Int J Mol Med. 47:171–182. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yeung K, Seitz T, Li S, Janosch P,
McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, et
al: Suppression of Raf-1 kinase activity and MAP kinase signalling
by RKIP. Nature. 401:173–177. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Noh HS, Hah YS, Zada S, Ha JH, Sim G,
Hwang JS, Lai TH, Nguyen HQ, Park JY, Kim HJ, et al: PEBP1, a RAF
kinase inhibitory protein, negatively regulates starvation-induced
autophagy by direct interaction with LC3. Autophagy. 12:2183–2196.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang Y, Song X, Wang X, Hu J and Jiang L:
Silencing of LncRNA HULC enhances chemotherapy induced apoptosis in
human gastric cancer. J Med Biochem. 35:137–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou Y, Zhang Y, Shao Y, Yue X, Chu Y,
Yang C and Chen D: LncRNA HOTAIR down-expression inhibits the
invasion and tumorigenicity of epithelial ovarian cancer cells by
suppressing TGF-β1 and ZEB1. Discov Oncol. 14:2282023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Casagrande N, Borghese C, Agostini F,
Durante C, Mazzucato M, Colombatti A and Aldinucci D: In ovarian
cancer multicellular spheroids, platelet releasate promotes growth,
expansion of ALDH+ and CD133+ cancer stem cells, and protection
against the cytotoxic effects of cisplatin, carboplatin and
paclitaxel. Int J Mol Sci. 22:30192021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ma N, Zhang M, Hu J, Wei Z and Zhang S:
Daphnetin induces ferroptosis in ovarian cancer by inhibiting
NAD(P)H:Quinone oxidoreductase 1 (NQO1). Phytomedicine.
132:1558762024. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wojtowicz K and Nowicki M: The
characterization of the sensitive ovarian cancer cell lines A2780
and W1 in response to ovarian CAFs. Biochem Biophys Res Commun.
662:1–7. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li X, Guo Y, Xing Z, Gong T, Yang L, Yang
T, Chang B, Wang X, Yu B and Guo R: ABT-737 increases cisplatin
sensitivity through the ROS-ASK1-JNK MAPK signaling axis in human
ovarian cancer cisplatin-resistant A2780/DDP cells. Oncol Rep.
52:1222024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang DY, Li N and Cui YL: Long non-coding
RNA CCAT1 sponges miR-454 to promote chemoresistance of ovarian
cancer cells to cisplatin by regulation of surviving. Cancer Res
Treat. 52:798–814. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang B, Liu M, Zhuang R, Jiang J, Gao J,
Wang H, Chen H, Zhang Z, Kuang Y and Li P: Long non-coding RNA
CCAT2 promotes epithelial-mesenchymal transition involving
Wnt/β-catenin pathway in epithelial ovarian carcinoma cells. Oncol
Lett. 15:3369–3375. 2018.PubMed/NCBI
|
|
33
|
Wang H, Ge W, Jiang W, Li D and Ju X:
SRPK1-siRNA suppresses K562 cell growth and induces apoptosis via
the PARP-caspase3 pathway. Mol Med Rep. 17:2070–2076.
2018.PubMed/NCBI
|
|
34
|
Li S, Lv C, Li J, Xie T, Liu X, Zheng Z,
Qin Z, Hui X and Yu Y: LncRNA LINC00473 promoted colorectal cancer
cell proliferation and invasion by targeting miR-195 expression. Am
J Transl Res. 13:6066–6075. 2021.PubMed/NCBI
|
|
35
|
Ding LN, Yu YY, Ma CJ, Lei CJ and Zhang
HB: SOX2-associated signaling pathways regulate biological
phenotypes of cancers. Biomed Pharmacother. 160:1143362023.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu C, Barger CJ and Karpf AR: FOXM1: A
multifunctional oncoprotein and emerging therapeutic target in
ovarian cancer. Cancers (Basel). 13:30652021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Disis ML, Taylor MH, Kelly K, Beck JT,
Gordon M, Moore KM, Patel MR, Chaves J, Park H, Mita AC, et al:
Efficacy and safety of Avelumab for patients with recurrent or
refractory ovarian cancer: Phase 1b results from the JAVELIN solid
tumor trial. JAMA Oncol. 5:393–401. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fu Y, Zhang Y, Cui J, Yang G, Peng S, Mi
W, Yin X, Yu Y, Jiang J, Liu Q, et al: SNP rs12982687 affects
binding capacity of lncRNA UCA1 with miR-873-5p: involvement in
smoking-triggered colorectal cancer progression. Cell Commun
Signal. 18:372020. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang X, Zhang H, Yin S, Yang Y, Yang H,
Yang J, Zhou Z, Li S, Ying G and Ba Y: lncRNA-encoded pep-AP
attenuates the pentose phosphate pathway and sensitizes colorectal
cancer cells to oxaliplatin. EMBO Rep. 23:e531402022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang J, Wang S, Wang Z, Cai J, Han L, Xie
L, Han Q, Wang W, Zhang Y, He X and Yang C: HOTAIR promotes
paclitaxel resistance by regulating CHEK1 in ovarian cancer. Cancer
Chemother Pharmacol. 86:295–305. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kielbik M, Szulc-Kielbik I and Klink M:
Impact of selected signaling proteins on SNAIL 1 and SNAIL 2
expression in ovarian cancer cell lines in relation to cells'
cisplatin resistance and EMT markers level. Int J Mol Sci.
22:9802021. View Article : Google Scholar : PubMed/NCBI
|
